|
|||||
       |
(National Institute of General Medical Sciences, NIH) 16 June 2015. A report released today by Biotechnology Industry Organization, or Bio, indicates academic research labs are playing an increasingly key role in research and development of new therapies, but it also highlights areas where partnerships between academia and industry are still evolving. Bio released . . . → Read More: Report Evaluates Industry-Academic Biotech Partner Roles  Comments are closed  Business conditions, Joint ventures/collaborations  biomedical, biotechnology, clinical trials, FDA, life sciences, NIH, patent, pharmaceuticals, preclinical, university Stefan Bossmann, left, and Deryl Troyer (Kansas State University) 16 June 2015. Three researchers at Kansas State University in Manhattan received a patent for an early-stage test that the inventors say can diagnose some solid tumor cancers well before symptoms develop. Kansas State chemistry professor Stefan Bossmann and anatomy-physiology professor Deryl Troyer, with . . . → Read More: Patent Awarded for Early, Pre-Symptom Cancer Tests Comments are closed Intellectual property Asia, biomedical, biotechnology, cancer, chemistry, China, clinical trials, life sciences, medical device, nanotechnology, patent, physical sciences, university, USPTO (LSC, Pixabay) 10 June 2015. Science & Enterprise is taking a break from blogging for a few days. We’ll return on Tuesday, 16 June. * * * Mark One team (MyVessyl.com) 10 June 2015. The venture capital division of semiconductor manufacturer Intel unveiled a fund to invest in technology start-ups founded by women and under-represented minorities. Intel Capital announced as well the first four investments from its Capital Diversity Fund, which expects to distribute some $125 million over the next . . . → Read More: Intel Begins $125M Diversity Investment Fund Comments are closed Business conditions, Finance computer science, engineering, entrepreneurs, equity, investment, semiconductors, software, venture capital Microscopic image of needle-like gout crystals (Bobjgalindo, Wikimedia Commons) 10 June 2015. An early-stage clinical trial is recruiting patients to test the safety of a treatment for severe gout that harnesses the immune system, but still avoids unwanted immune responses. The trial is conducted by the biotechnology company Selecta Biosciences at two sites . . . → Read More: Trial Underway Testing Immunotherapy for Gout Comments are closed New products, Regulations Asia, biomedical, biotechnology, China, clinical trials, licensing, life sciences, nanotechnology, pharmaceuticals Kristina Trujillo (Exovita Biosciences) 9 June 2015. A new $1.7 million grant from National Cancer Institute is funding research at University of New Mexico on harnessing exosomes as potential cancer therapies, with a spin-off company already optioning the technology for commercial development. The alliance between the university and spin-off company, Exovita Biosciences, includes . . . → Read More: Grant Funds Exosome Cancer Research, Optioned to Spin-Off One comment - (Comments are closed) Finance, Intellectual property biomedical, biotechnology, cancer, entrepreneurs, genomics, grant, licensing, life sciences, NIH, pharmaceuticals, university Microscopic image showing the soft wire mesh being injected through a glass needle less than 100 micrometers in diameter. (Lieber Research Group, Harvard University) 9 June 2015. Researchers at Harvard University developed a tiny electronic wire mesh that can be injected into the brain and demonstrated its diagnostic and therapeutic potential with lab . . . → Read More: Injectable Neuro-Electronic Wire Mesh Demonstrated Comments are closed New products biomedical, chemistry, engineering, life sciences, materials science, medical device, patent, physical sciences, university (Greyerbaby, Pixabay) 8 June 2015. An alliance of drug, genomic, and assisted fertility technology companies are collaborating on processes and standards that encourage more consistency in results from assisted reproductive treatment labs. Financial details of the Global Fertility Alliance joining Illumina, Merck, and Genea were not disclosed. The three companies aim to improve . . . → Read More: Companies Form Fertility Treatment Technologies Alliance Comments are closed Joint ventures/collaborations, Regulations Australia, biomedical, Europe, genomics, life sciences, medical device, standard Pseudomonas aeruginosa bacteria (National Institute of Environmental Health Sciences, NIH) 8 June 2015. Spero Therapeutics, a developer of antibiotics, is adding a new class of anti-infection drugs to its pipeline, and raised another $30 million to its first venture funding round. The Cambridge, Massachusetts biotechnology company, a spin-off from Massachusetts General Hospital in . . . → Read More: Biotech Adds Antibiotic Program, Raises $30 Million One comment - (Comments are closed) Finance, Intellectual property biomedical, biotechnology, chemistry, entrepreneurs, equity, investment, licensing, life sciences, pharmaceuticals, venture capital Scanning electron micrograph of HIV particles infecting a human T cell (NIH.gov) 5 June 2015. The U.S. Food and Drug Administration approved an application for a current HIV drug formulated to better treat infections in infants and young children, especially in limited resource regions. The formulation is a combination of lopinavir and ritonavir . . . → Read More: FDA Approves Pediatric HIV Drug Formulation Comments are closed Intellectual property, Regulations Africa, biomedical, FDA, HIV, India, licensing, life sciences, patent, pharmaceuticals |
||||
|
Copyright © 2024 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||
RSS - Posts
You must be logged in to post a comment.